2nd Biosimilars & Biobetters Congress
03 Apr 2014 - 04 Apr 2014 - London, UK
Over two days, the 2nd Annual Biosimilars and Biobetters Congress will attract over 175 senior decision makers from Europe and the US with a comprehensive conference program featuring two separate streams, keynote addresses, case study presentations and interactive panel discussions given by over 25 expert speakers from leading pharmaceutical, biotech, academic and research institutes.
The congress features two streams:
Market Opportunities & Commercial Challenges: In Stream 1, the meeting will address the most pressing challenges in gaining access to emerging markets and branding biosimilars through a series of cutting-edge conference presentations. Our boisimilars experts will also debate how to overcome regulatory challenges, outsource manufacturing and develop pricing strategies
Developing Biosimilars & Biobetters: Learn more about current developments in clinical trials, including pharmacovigilence and patient safety. Do not miss out on the chance to discover innovative solutions for achieving quality by design, demonstrating biosimilarity and addressing potency as well as the latest insights into the regulatory requirements and trial design.
This meeting is the single most senior-level focused event in Europe, dedicated to key technological and scientific advances in the follow on biologics industry.
Contact Kathryn Randall to download the agenda and for attendance information on email@example.com or call +44 (0)1865 248455